CYCN
Cyclerion Therapeutics, Inc. - Common Stock (CYCN)
$27
About Cyclerion Therapeutics, Inc. - Common Stock (CYCN)
Cyclerion Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of human therapeutics. Its product pipeline includes several sGC stimulators, small molecules that act synergistically with nitric oxide on sGC to boost production of cyclic guanosine monophosphate. The company was founded on September 6, 2018 and is headquartered in Cambridge, MA.
Details
Daily high
$3.27
Daily low
$3.10
Price at open
$3.10
52 Week High
$9.47
52 Week Low
$1.27
Market cap
10.5M
Dividend yield
0.00%
Volume
3,922
Avg. volume
17,033
P/E ratio
-2.81
Cyclerion Therapeutics, Inc. - Common Stock News
Details
Daily high
$3.27
Daily low
$3.10
Price at open
$3.10
52 Week High
$9.47
52 Week Low
$1.27
Market cap
10.5M
Dividend yield
0.00%
Volume
3,922
Avg. volume
17,033
P/E ratio
-2.81